Product Information

RIFAMPIN 150 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.9084 per EA under NDC 60687057521. Its NADAC has been published 290 times since May 5, 2021.

FDA first approved this application on Aug 21, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIFAMPIN 150 MG CAPSULE

Rifampin
$0.9084per EA

Strength

150 mg/1

NDC

60687057521

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

RIFAMPIN

Approval Type

Generic (ANDA)

FDA Application

ANDA090034

FDA Approved

8/21/2013

TE Code

AB

On Market Since

3/5/2021

Pharmacological Classes

Price Statistics

The NADAC for RIFAMPIN 150 MG CAPSULE has been published 290 times since May 5, 2021, and over the history we have for it it has declined 3.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9084 per EA
All-time high$1.3166 (Jan 10, 2024)
All-time low$0.5653 (Nov 20, 2024)
52-week high$0.9816
52-week low$0.5959
Median price$0.7771
Average price$0.7890
Largest weekly change+66.2% (Dec 20, 2023)
Weeks tracked290
Tracking sinceMay 5, 2021

Price History

1W

-7.5%

1M

+1.2%

3M

+13.1%

6M

+51.0%

1Y

+44.2%

3Y

-14.9%

5Y

-9.7%

All

-3.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Rifampin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIFAMPIN 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 150 MG CAPSULE, manufactured by American Health Packaging, is $0.9084 per EA (NDC 60687057521), effective Nov 18, 2026.

How has the price of RIFAMPIN 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIFAMPIN 150 MG CAPSULE has declined 3.9%. It has been tracked across 290 weekly CMS publications since May 5, 2021.

What are the highest and lowest recorded NADAC prices for RIFAMPIN 150 MG CAPSULE?

Since May 5, 2021, the NADAC for RIFAMPIN 150 MG CAPSULE has ranged from a low of $0.5653 (Nov 20, 2024) to a high of $1.3166 (Jan 10, 2024), with a median of $0.7771 per EA.

Are there cheaper alternatives to RIFAMPIN 150 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of RIFAMPIN 150 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures RIFAMPIN 150 MG CAPSULE?

RIFAMPIN 150 MG CAPSULE (NDC 60687057521) is labeled by American Health Packaging, and CMS classifies it as a generic product.